Things that You Have to Know About Bipolar Depression
You must understand that bipolar disorder is a kind of condition which affects all types of individuals. Children and adults are affected by this condition. This is a fact that you should know. Women would suffer the most from this kind of depression that is called bipolar depression disorder.
This isn’t very strange or far-fetched in any case, since even when the women would suffer from such regular bipolar kind of depression or the depressive disorder, they would often spend more time depressed than they do being manic. Not only women are depressive but the men also are and they could also be affected by this condition.
The bipolar kind of disorder is also known as manic depression since such is a mental condition wherein you interchange often between such phases of depression and mania. If you suffer from such bipolar depression, you won’t have to spend a lot of time being manic as you spend getting depressed.
This kind of depression is one form of disorder and you should understand it is easy to wrongly diagnose as bipolar disorder due to the similarity of such symptoms. Because of such, the doctor must keep you around for such a long time when they would try to diagnose the condition you have. It certainly won’t be flattering to either of you when you are treated for a wrong thing.
The bipolar affective disorder is another name for such bipolar disorder or the manic-depressive illness. But, you don’t like to mistake this for bipolar depression disorder. Such is related with those symptoms of such depressive phase of bipolar disorder but only a few of the mania.
Monotherapy trials against the placebo is the gold-standard design when determining the efficacy in treating bipolar depression. When such efficacy would be proven as monotherapy, the new compounds can be tested in the adjunctive-medication placebo-controlled trials. Those younger adults, without the established need for such long-term medication can be suitable for the clinical trials needing placebo-controls. The switch to mania or such hypomania can be a consequence of the active treatment for such bipolar depression.
Some medications like the tricyclic antidepressants as well as venlafaxine can be more likely to prove switch unlike the others but such increased rate of the switch can’t be seen until around ten weeks of treatment. The 12-week trials against placebo are needed to determine the risk of switch and also to establish the continuing effects. Know that such careful assessments at six to eight weeks are needed to ensure that the patients who fail to respond don’t continue in the study for such unacceptable periods of time.